Experts estimate that over 13,000 new cervical cancer diagnoses occurred in the United States in 2025, accompanied by over 4,000 cervical cancer-related deaths. Five-year survival for patients ...
ICMR has licensed the anti-HPV candidate SHetA2 to Emcure Pharmaceuticals for further development. The move could open a ...
Most people with cervical cancer begin treatment by having surgery to remove their cancer. For some early cancers, this might be the only treatment you need. Some people will have other treatments too ...
New data suggested that laparoscopic radical hysterectomy that uses modified tumor-free (MTF) techniques can improve outcomes for patients with early-stage cervical cancer. An editorialist, however, ...
Although the incidence of cervical cancer has declined with increased screening and higher uptake of human papillomavirus (HPV) vaccination, cervical cancer remains the second highest cause of cancer ...
The 19th World Congress of the International Federation for Cervical Pathology and Colposcopy (IFCPC) took place in Paris, France, in 2026. Held concurrently was an international expert consensus ...
Our editors independently select these products. Making a purchase through our links may earn Well+Good a commission Like most women, I don’t exactly look forward to gyno appointments. It’s nothing ...
People living in rural America are more likely to view cancer as a death sentence, a new survey reports. About 43% of people living in rural areas say a cancer diagnosis means inevitable death, ...
SHetA2 targets HPV-infected cells while largely sparing healthy tissue. If successful, it could offer a less invasive treatment for cervical precancer.
Racial Disparities in Endometrial Cancer Incidence and Outcomes in Brazil: Insights From Population-Based Registries Data (patient age, HIV status, margin status, follow-up, and recurrence) from women ...
Health and Me on MSN
SHETA2: India's indigenous drug candidate for cervical cancer
SHetA2 is an anti-HPV therapeutic being developed to treat Cervical Intraepithelial Neoplasia (CIN)— a precancerous condition caused by persistent human papillomavirus (HPV) infection— to prevent ...
Data (patient age, HIV status, margin status, follow-up, and recurrence) from women who underwent LEEP with histologically confirmed CIN 2/3 between January 2014 and December 2015 were analyzed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results